A question to those that are more across CYC.
Looking back at a presentation from last year it had the per patient fee at $140, which multiplied by an addressable market of 600k patients gets close enough to the 90M USD market. Yet looking at the latest pricing, it now sits at 225 per patient. Was there any reasoning behind this change, as it has an enormous difference to revenue numbers
they have restated they expect 50% of the market in 2-3 years which equates to 300 000 procedures. By my calcs this would equate to 70-80 M USD.
This would have to be one of the best risk/reward plays out there for mine at the moment.
Looking forward to the rollout updates.
Ann: Cyclopharm Trading and USA Launch Update, page-31
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.67 |
Change
-0.025(1.47%) |
Mkt cap ! $185.5M | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.69 | $1.67 | $98.61K | 59.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 204 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.67 | 799 | 1 |
View Market Depth
| Last trade - 14.49pm 11/07/2024 (20 minute delay) ? |
| CYC (ASX) Chart |